Table 3.
Characteristics of the patients entering the randomized double-blind phase of the study
Lansoprazole (30 mg/d) (n = 17) | Lansoprazole (60 mg/d) (n = 18) | |
Age (mean±SD) | 57.5 ± 11.9 | 52.4±10.0 |
Gender, male (% ) | 3 (17.6) | 2 (11.1) |
Upper endoscopy positive (%) | 4 (23.5) | 3 (16.7) |
pH-metry positive (%) | 13 (76.5) | 10 (55.5) |
PPI test positive (%) | 11 (64.7) | 11 (61.1) |
No statistical differences between the groups in any of the parameters.